Vanguard Group
ORGO icon

Vanguard Group’s Organogenesis Holdings ORGO Stock Holding History

Vanguard Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$25.7M Sell
4,958,876
-77,144
-2% -$374K ﹤0.01% 2504
2025
Q3 		$21.3M Sell
5,036,020
-160,772
-3% -$747K ﹤0.01% 2591
2025
Q2 		$19M Buy
5,196,792
+765,378
+17% +$2.85M ﹤0.01% 2583
2025
Q1 		$19.1M Buy
4,431,414
+841,618
+23% +$3.4M ﹤0.01% 2525
2024
Q4 		$11.5M Sell
3,589,796
-82,636
-2% -$277K ﹤0.01% 2878
2024
Q3 		$10.5M Buy
3,672,432
+109,722
+3% +$308K ﹤0.01% 2930
2024
Q2 		$9.98M Buy
3,562,710
+27,411
+0.8% +$73.6K ﹤0.01% 2924
2024
Q1 		$10M Sell
3,535,299
-1,825,428
-34% -$6.2M ﹤0.01% 2959
2023
Q4 		$21.9M Buy
5,360,727
+1,665,088
+45% +$4.66M ﹤0.01% 2552
2023
Q3 		$11.8M Buy
3,695,639
+69,195
+2% +$220K ﹤0.01% 2790
2023
Q2 		$12M Sell
3,626,444
-88,022
-2% -$260K ﹤0.01% 2834
2023
Q1 		$7.91M Sell
3,714,466
-1,105,755
-23% -$2.73M ﹤0.01% 3068
2022
Q4 		$13M Buy
4,820,221
+340,584
+8% +$993K ﹤0.01% 2835
2022
Q3 		$14.5M Buy
4,479,637
+274,651
+7% +$1.24M ﹤0.01% 2769
2022
Q2 		$20.5M Sell
4,204,986
-400,271
-9% -$2.46M ﹤0.01% 2625
2022
Q1 		$35.1M Buy
4,605,257
+303,243
+7% +$2.35M ﹤0.01% 2483
2021
Q4 		$39.8M Buy
4,302,014
+112,990
+3% +$1.2M ﹤0.01% 2481
2021
Q3 		$59.7M Buy
4,189,024
+1,365,400
+48% +$21.2M ﹤0.01% 2265
2021
Q2 		$46.9M Buy
2,823,624
+1,281,893
+83% +$23.9M ﹤0.01% 2410
2021
Q1 		$28.1M Sell
1,541,731
-52,064
-3% -$705K ﹤0.01% 2608
2020
Q4 		$12M Buy
1,593,795
+1,295,611
+435% +$6.15M ﹤0.01% 2898
2020
Q3 		$1.14M Sell
298,184
-8,374
-3% -$33.1K ﹤0.01% 3626
2020
Q2 		$1.18M Buy
306,558
+44,370
+17% +$160K ﹤0.01% 3572
2020
Q1 		$848K Buy
262,188
+144
+0.1% +$616 ﹤0.01% 3542
2019
Q4 		$1.26M Sell
262,044
-63,020
-19% -$399K ﹤0.01% 3575
2019
Q3 		$2.13M Buy
325,064
+1,772
+0.5% +$9.86K ﹤0.01% 3430
2019
Q2 		$2.46M Buy
323,292
+80,852
+33% +$595K ﹤0.01% 3413
2019
Q1 		$1.82M Buy
+242,440
New +$4.84M ﹤0.01% 3478

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group's ORGO Position: Q4 2025 in Review

Vanguard Group reduced its Organogenesis Holdings (ORGO) stake by 1.5% in Q4 2025, selling an estimated $374K and leaving 4,958,876 shares worth $25.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2504.

Vanguard Group first reported a position in ORGO in Q1 2019 and has held it in 28 quarters since. The position peaked at $59.7M in Q3 2021. 147 funds tracked by Wall St. Rank hold ORGO as of Q4 2025.

  • Vanguard Group held 4,958,876 shares of Organogenesis Holdings worth $25.7M as of Q4 2025.
  • Vanguard Group sold 77,144 Organogenesis Holdings shares in Q4 2025, an estimated $374K.
  • Organogenesis Holdings made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2504 holding.
  • Vanguard Group first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 28 quarters since.
  • Vanguard Group's Organogenesis Holdings position peaked at $59.7M in Q3 2021.
  • 147 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.